Naproxen

CAS:
Other names: 2-Naphthaleneacetic acid, 6-methoxy-α-methyl-, (S)-; (+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid; Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-; CG 3117; Equiproxen; Floginax; (S)-6-Methoxy-α-methyl-2-naphthalene acetic acid; (+)-2-(Methoxy-2-naphthyl)-propionic acid; d-2-(6-Methoxy-2-naphthyl)propionic acid; d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure; (+)-2-(Methoxy-2-naphthyl)-propionsaeure; Mnpa; Naixan; 2-Naphthaleneacetic acid, 6-methoxy-α-methyl-, (+)-; Naprosine; Naprosyn; Naprux; Naxen; Naxyn; Proxen; RS-3540; (+)-6-Methoxy-α-methyl-2-napthaleneacetic acid; Bonyl; Diocodal; Dysmenalgit; Laraflex; Laser; Napren; Naprium; Naprius; Naprosyne; Nycopren; Panoxen; Prexan; Proxine; Reuxen; Veradol; Xenar; 2-(6-Methoxy-2-naphthyl)propanoic acid
SMILES: COc1ccc2cc(ccc2c1)C(C)C(O)=O

Properties

MW HBA HBD LogP TPSA Rot. Comp. Fsp3C Brutto formula
230.26 3 1 3.04 46.53 3 41 0.21 C14H14O3

Availability

Suppliers Supplier IDs Storage Storage ID Quantity Class Added
nt1558 None Jan. 1, 2023

Bar codes

Plate barcode Sample barcode

PAINS

Identified PAINS
Not checked

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[Naproxen] 3.14 25.0 Kenneth A. Connors 1995
[b-Cyclodextrin](1).[Naproxen] 3.98 1.95 2.0 15.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.76 1.95 2.0 25.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.58 2.46 2.0 35.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.40 2.41 2.0 45.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.89 1.90 3.0 15.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.71 2.80 3.0 25.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.53 2.41 3.0 35.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.36 2.08 3.0 45.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.74 2.43 4.0 15.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.57 2.76 4.0 25.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.39 1.70 4.0 35.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.23 4.0 45.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.48 1.48 5.0 15.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.19 1.60 5.0 25.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.06 2.00 5.0 35.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.00 1.95 5.0 45.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.32 1.85 6.0 15.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.17 1.85 6.0 25.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 3.05 6.0 35.0 Fluorescence spectroscopy I. Vélaz 1997
[b-Cyclodextrin](1).[Naproxen] 2.87 1.30 6.0 45.0 Fluorescence spectroscopy I. Vélaz 1997
Comment